- Home
- RVSN vs CYCC Comparison
RVSN vs CYCC Comparison
Compare RVSN & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- CYCC
- Stock Information
- Founded
- RVSN 2016
- CYCC 1992
- Country
- RVSN Israel
- CYCC Malaysia
- Employees
- RVSN N/A
- CYCC N/A
- Industry
- RVSN
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- CYCC Health Care
- Exchange
- RVSN Nasdaq
- CYCC Nasdaq
- Market Cap
- RVSN 6.6M
- CYCC 7.8M
- IPO Year
- RVSN 2022
- CYCC N/A
- Fundamental
- Price
- RVSN $0.35
- CYCC $14.35
- Analyst Decision
- RVSN
- CYCC
- Analyst Count
- RVSN 0
- CYCC 0
- Target Price
- RVSN N/A
- CYCC N/A
- AVG Volume (30 Days)
- RVSN 508.6K
- CYCC 4.8M
- Earning Date
- RVSN 08-29-2025
- CYCC 08-13-2025
- Dividend Yield
- RVSN N/A
- CYCC N/A
- EPS Growth
- RVSN N/A
- CYCC N/A
- EPS
- RVSN N/A
- CYCC N/A
- Revenue
- RVSN $1,300,000.00
- CYCC $14,000.00
- Revenue This Year
- RVSN $1,861.54
- CYCC $137.21
- Revenue Next Year
- RVSN N/A
- CYCC N/A
- P/E Ratio
- RVSN N/A
- CYCC N/A
- Revenue Growth
- RVSN 815.49
- CYCC N/A
- 52 Week Low
- RVSN $0.27
- CYCC $3.08
- 52 Week High
- RVSN $2.72
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- RVSN 50.00
- CYCC 48.68
- Support Level
- RVSN $0.32
- CYCC $3.27
- Resistance Level
- RVSN $0.36
- CYCC $19.25
- Average True Range (ATR)
- RVSN 0.03
- CYCC 1.81
- MACD
- RVSN 0.00
- CYCC 1.72
- Stochastic Oscillator
- RVSN 55.45
- CYCC 34.93
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.